Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 139

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 139
---
 4/5/2023  | 7/2/2039   | Issued  | Antev Limited |
| United States | Reconstitutable teverelix-TFA composition |  18/122,991 | 7/5/2018 | 3/17/2023  |            |           | 7/2/2039   | Pending | Antev Limited |
| Europe        | Reconstitutable teverelix-TFA composition |  18181931.9 | 7/5/2018 | 7/5/2018   |    3590524 | 11/4/2020 | 7/2/2039   | Issued  | Antev Limited |
| Europe        | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |
| Germany       | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |
| France        | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |
| Great Britain | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |
| Sweden        | Reconstitutable teverelix-TFA composition |  19740498.1 | 7/5/2018 | 7/2/2019   |    3817759 | 7/27/2022 | 7/2/2039   | Issued  | Antev Limited |
|